Efficacy and safety of bexarotene combined with phototherapy in Japanese patients with Cutaneous T-cell Lymphomas

Trial Profile

Efficacy and safety of bexarotene combined with phototherapy in Japanese patients with Cutaneous T-cell Lymphomas

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Bexarotene (Primary)
  • Indications Cutaneous T cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2017 Last checked against University Hospital Medical Information Network - Japan record.
    • 24 Oct 2017 Status changed from recruiting to active, no longer recruiting.
    • 25 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top